AKT1 and Parkinson disease: Thus, Kim et al. [50] have recently demonstrated the neuroprotective effects of HN treatment in in vitro and ex vivo/in vivo PD models, which seem to promote mitochondrial biogenesis mainly via the PI3K/AKT signaling pathway.